Search clinical trials for: Avapritinib
Total 22 results
-
H. Lee Moffitt Cancer Center and Research InstituteBlueprint Medicines CorporationRecruitingSystemic Mastocytosis With an Associated Hematologic NeoplasmUnited States
-
Children's Hospital of Soochow UniversityRecruitingAML, Childhood | C-KIT Mutation | Refractory AML | Relapse/Recurrence | Core Binding Factor Acute Myeloid LeukemiaChina
-
Children's Hospital of Soochow UniversityRecruitingAcute Myeloid Leukemia | AML, ChildhoodChina
-
The First Affiliated Hospital of Soochow UniversityRecruitingCore Binding Factor Acute Myeloid Leukemia | KIT Mutation-Related TumorsChina
-
Xinhua Zhang, MDXijing Hospital; Chongqing University Cancer Hospital; Xiangya Hospital of Central... and other collaboratorsNot yet recruitingGastrointestinal Stromal Tumors | Unresectable Solid Tumor | Recurrent Metastatic Malignant Neoplasm
-
Xinhua Zhang, MDXijing Hospital; Chongqing University Cancer Hospital; Xiangya Hospital of Central... and other collaboratorsNot yet recruitingGastrointestinal Stromal Tumors | Unresectable Solid Tumor | Recurrent Metastatic Malignant Neoplasm
-
CStone PharmaceuticalsRecruitingGastrointestinal Stromal TumorsChina
-
Blueprint Medicines CorporationRecruitingCNS Tumor | Solid Tumor, Unspecified, Child | Relapsed Solid NeoplasmUnited States, Korea, Republic of, United Kingdom, France, Canada, Australia, Austria, Germany, Italy
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPrognostic Stage IIIC Breast Cancer AJCC v8 | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Melanoma | Stage IV Lung Cancer AJCC v8 | Locally Advanced Malignant Solid Neoplasm | Locally... and other conditionsUnited States
-
Centre Leon BerardRecruiting
-
Blueprint Medicines CorporationCompletedGastrointestinal Stromal Tumors | GIST | Non-resectable Advanced Solid Tumors | Recurrent or Unresectable Central Nervous System (CNS) TumorsUnited States
-
Centre Leon BerardBlueprint Medicines CorporationActive, not recruitingGIST, Malignant | GIST | PDGFR-Alpha D842VFrance
-
Blueprint Medicines CorporationActive, not recruitingMast Cell Leukemia | Aggressive Systemic Mastocytosis | Advanced Systemic Mastocytosis | Systemic Mastocytosis With an Associated Hematologic NeoplasmUnited States, Canada, United Kingdom, France, Netherlands, Italy, Spain, Austria, Denmark, Germany, Norway, Poland
-
Blueprint Medicines CorporationActive, not recruitingGastrointestinal Stromal TumorsFrance
-
Blueprint Medicines CorporationActive, not recruitingIndolent Systemic MastocytosisCanada, United States, Spain, United Kingdom, Germany, Belgium, Switzerland, Italy, Netherlands, Denmark, France, Norway, Sweden
-
Blueprint Medicines CorporationCompletedMast Cell Leukemia | Aggressive Systemic Mastocytosis | Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease | Relapsed or Refractory Myeloid MalignanciesUnited States, United Kingdom
-
Blueprint Medicines CorporationCompletedGISTUnited States, Korea, Republic of, Netherlands, China, France, Spain, Italy, Belgium, United Kingdom, Singapore, Australia, Canada, Germany, Sweden, Hungary, Austria, Czechia, Poland
-
Blueprint Medicines CorporationCompletedGastrointestinal Stromal Tumors (GIST) | Other Relapsed or Refractory Solid TumorsUnited States, United Kingdom, France, Korea, Republic of, Belgium, Germany, Italy, Netherlands, Poland, Spain
-
Blueprint Medicines CorporationAnalysis Group, Inc.CompletedMast Cell Leukemia | Aggressive Systemic Mastocytosis | Advanced Systemic Mastocytosis | Systemic Mastocytosis With an Associated Hematological NeoplasmUnited States, Austria, Germany, Spain, United Kingdom
-
Presage BiosciencesNorthwell Health; Oregon Health and Science University; University of Washington and other collaboratorsCompletedSoft Tissue Sarcoma AdultUnited States
-
Blueprint Medicines CorporationApproved for marketing